glucose, (beta-d)-isomer has been researched along with Hyperuricemia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 7 (46.67) | 2.80 |
| Authors | Studies |
|---|---|
| Anker, SD; Brueckmann, M; Butler, J; Doehner, W; Ferreira, JP; Filippatos, G; Januzzi, JL; Kaempfer, C; Packer, M; Pocock, SJ; Salsali, A; Zannad, F | 1 |
| An, J; Li, C; Li, Y; Lin, F; Ma, S; Wang, S; Xie, Y; Xu, L; Zhang, Y; Zhao, Y | 1 |
| Harada-Shiba, M; Hirata, H; Ogura, M; Ota-Kontani, A; Tsuchiya, Y | 1 |
| Chang, YP; Chen, LM; Cheng, Y; Han, F; Han, Z; Li, CJ; Li, T; Li, XY; Lu, YH; Meng, ZY; Sun, B; Xue, M | 1 |
| Cao, LH; Kang, L; Liu, HJ; Miao, JX; Miao, MS; Miao, YY; Song, YG; Xiang, LL | 1 |
| Gong, M; Han, B; Li, Z; Qiu, Y; Zou, Z | 1 |
| Dronamraju, N; Erlandsson, F; Goldwater, R; Han, D; Johansson, S; Johnsson, E; Oscarsson, J; Parkinson, J; Stack, AG | 1 |
| Chen, L; Lan, Z | 1 |
| Chen, L; Tian, D; Wang, L; Xia, P; Xu, L; Zhao, Y; Zheng, H | 1 |
| Chang, WX; Kumagai, T; Shibata, S; Tamura, Y; Uchida, S | 1 |
| Boulton, DW; Griffen, SC; Leslie, BR; Shen, W; Wilcox, CS | 1 |
| Hu, YJ; Liang, WQ; Lin, Y; Liu, PG; Pu, JB; Xu, P; Zhang, HJ; Zhou, J | 1 |
| Jiang, H; Wu, G; Wu, HB | 1 |
| Chen, M; Fu, G; Wan, Y; Zeng, H; Zhang, L; Zou, B | 1 |
| Hong, Y; Kong, LD; Li, Z; Liu, L; Liu, YL; Shi, YW; Wang, CP; Wang, X | 1 |
2 review(s) available for glucose, (beta-d)-isomer and Hyperuricemia
| Article | Year |
|---|---|
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta-analysis of randomized controlled trials.
Topics: Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Glucosides; Humans; Hyperglycemia; Hyperuricemia; Hypoglycemia; Hypoglycemic Agents; Membrane Transport Modulators; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Uric Acid | 2018 |
Time to Target Uric Acid to Retard Chronic Kidney Disease Progression.
Topics: Allopurinol; Animals; Anion Transport Proteins; ATP Binding Cassette Transporter, Subfamily G, Member 2; Disease Progression; Enzyme Inhibitors; Febuxostat; Glucosides; Gout Suppressants; Humans; Hyperuricemia; Monosaccharide Transport Proteins; Nitriles; Oxidative Stress; Pyridines; Renal Insufficiency, Chronic; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Uric Acid; Xanthine Oxidase | 2018 |
3 trial(s) available for glucose, (beta-d)-isomer and Hyperuricemia
| Article | Year |
|---|---|
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucose; Glucosides; Heart Failure; Humans; Hyperuricemia; Male; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Uric Acid | 2022 |
Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study.
Topics: Adult; Benzhydryl Compounds; Cross-Over Studies; Drug Therapy, Combination; Enzyme Inhibitors; Febuxostat; Female; Glucosides; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Naphthalenes; Propionates; Pyridines; Treatment Outcome; United States; Uric Acid; Uricosuric Agents; Young Adult | 2021 |
Interaction Between the Sodium-Glucose-Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects.
Topics: Adolescent; Adult; Benzhydryl Compounds; Bumetanide; Drug Interactions; Female; Glucosides; Healthy Volunteers; Humans; Hyperuricemia; Male; Middle Aged; Natriuresis; Renal Elimination; Risk Assessment; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Sodium, Dietary; Uric Acid; Young Adult | 2018 |
10 other study(ies) available for glucose, (beta-d)-isomer and Hyperuricemia
| Article | Year |
|---|---|
Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters.
Topics: Animals; Apigenin; Creatinine; Glucosides; Gout; Hyperuricemia; Kidney; Malondialdehyde; Mice; Molecular Docking Simulation; Organic Anion Transporters; Oxonic Acid; Paeonia; Superoxide Dismutase; Uric Acid; Xanthine Oxidase | 2023 |
Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Glucose Transport Proteins, Facilitative; Glucosides; Hesperidin; Hyperuricemia; Intestine, Small; Kidney; Liver; Male; Mice, Inbred C57BL; Organic Anion Transporters; Oxonic Acid; Uric Acid; Xanthine Oxidase | 2020 |
Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice.
Topics: AMP-Activated Protein Kinases; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzhydryl Compounds; Blotting, Western; Cell Line; Chromatin Immunoprecipitation; Cyclic AMP Response Element-Binding Protein; Diabetes Mellitus, Type 2; Glucosides; HEK293 Cells; Humans; Hyperuricemia; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2020 |
Total glucosides of herbaceous peony (Paeonia lactiflora Pall.) flower attenuate adenine- and ethambutol-induced hyperuricaemia in rats.
Topics: Adenine; Animals; Biomarkers; Disease Models, Animal; Down-Regulation; Ethambutol; Flowers; Glucosides; Hyperuricemia; Kidney; Male; Paeonia; Plant Extracts; Rats, Wistar; Uric Acid; Uricosuric Agents | 2020 |
NMR-Based Metabonomic Study Reveals Intervention Effects of Polydatin on Potassium Oxonate-Induced Hyperuricemia in Rats.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Drugs, Chinese Herbal; Glucosides; Humans; Hyperuricemia; Kidney; Male; Metabolomics; Oxonic Acid; Rats; Rats, Sprague-Dawley; Stilbenes; Uric Acid | 2020 |
Polydatin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation by inhibiting NF-κB/NLRP3 inflammasome activation via the AMPK/SIRT1 pathway.
Topics: AMP-Activated Protein Kinases; Animals; Glucosides; Humans; Hyperuricemia; Inflammasomes; Kidney; Male; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxonic Acid; Rats; Rats, Sprague-Dawley; Sirtuin 1; Stilbenes | 2017 |
Luteolin-4'-O-glucoside and its aglycone, two major flavones of Gnaphalium affine D. Don, resist hyperuricemia and acute gouty arthritis activity in animal models.
Topics: Animals; Arthritis, Gouty; Disease Models, Animal; Drugs, Chinese Herbal; Edema; Glucose Transport Proteins, Facilitative; Glucosides; Gnaphalium; Hyperuricemia; Interleukin-1beta; Kidney; Luteolin; Male; Mice, Inbred ICR; Organic Anion Transporters; Uric Acid; Xanthine Oxidase | 2018 |
[Anti-hyperuricemia effect and mechanism of polydatin in mice].
Topics: Animals; Disease Models, Animal; Glucosides; Hyperuricemia; Kidney; Mice; Stilbenes; Uric Acid | 2014 |
Inhibitory effect of verbascoside on xanthine oxidase activity.
Topics: Animals; Enzyme Inhibitors; Glucosides; Hyperuricemia; Liver; Male; Molecular Docking Simulation; Phenols; Protein Structure, Secondary; Rats; Rats, Sprague-Dawley; Uric Acid; Xanthine Oxidase | 2016 |
Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blood Urea Nitrogen; Carrier Proteins; Creatinine; Disaccharides; Gene Expression Regulation; Glucose Transport Proteins, Facilitative; Glucosides; Gout Suppressants; Hyperuricemia; Kidney; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Octamer Transcription Factor-1; Organic Anion Transport Protein 1; Organic Anion Transporters; Organic Cation Transport Proteins; Organic Cation Transporter 2; Oxonic Acid; Resveratrol; Solute Carrier Family 22 Member 5; Stilbenes; Symporters; Uric Acid | 2012 |